{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:17:23Z","timestamp":1790320643154,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Correlates of protection (CoPs) against the highly contagious respiratory disease whooping cough, caused by <jats:italic>Bordetella pertussis<\/jats:italic>, remain elusive. Characterizing the antibody response to this pathogen is essential towards identifying potential CoPs. Here, we evaluate levels, avidity and functionality of <jats:italic>B<\/jats:italic>. <jats:italic>pertussis-<\/jats:italic>specific-antibodies from paired plasma samples derived from symptomatic and recovered pertussis patients, as well as controls. Natural infection is expected to induce protective immunity. IgG levels and avidity to nine <jats:italic>B<\/jats:italic>. <jats:italic>pertussis<\/jats:italic> antigens were determined using a novel multiplex panel. Furthermore,\u00a0opsonophagocytosis of a <jats:italic>B<\/jats:italic>. <jats:italic>pertussis<\/jats:italic> clinical isolate by neutrophils was measured. Findings indicate that following infection, <jats:italic>B<\/jats:italic>. <jats:italic>pertussis-<\/jats:italic>specific antibody levels of (ex-) pertussis patients waned, while the avidity of antibodies directed against the majority of studied antigens increased. Opsonophagocytosis indices decreased upon recovery, but remained higher than controls. Random forest analysis of all the data revealed that 28% of the opsonophagocytosis index variances could be explained by filamentous hemagglutinin- followed by pertussis toxin-specific antibodies. We propose to further explore which other <jats:italic>B<\/jats:italic>. <jats:italic>pertussis-<\/jats:italic>specific antibodies can better predict opsonophagocytosis. Moreover, other <jats:italic>B<\/jats:italic>. <jats:italic>pertussis-<\/jats:italic>specific antibody functions as well as the possible integration of these functions in combination with other immune cell properties should be evaluated towards the identification of CoPs against pertussis.<\/jats:p>","DOI":"10.1038\/s41598-018-30558-8","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T11:08:46Z","timestamp":1533640126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients"],"prefix":"10.1038","volume":"8","author":[{"given":"Elise S.","family":"Hovingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel A","family":"Bona\u010di\u0107 Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Jan Hamstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Hijdra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lapo","family":"Mughini Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inonge","family":"van Twillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Jongerius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A. C. M.","family":"van Els","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"30558_CR1","doi-asserted-by":"publisher","unstructured":"Tan, T. et al. Pertussis Across the Globe: Recent Epidemiologic Trends From 2000\u20132013. Pediatr Infect Dis J, https:\/\/doi.org\/10.1097\/INF.0000000000000795 (2015).","DOI":"10.1097\/INF.0000000000000795"},{"key":"30558_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.inf.0000177282.53500.77","volume":"24","author":"LP Celentano","year":"2005","unstructured":"Celentano, L. P. et al. Resurgence of pertussis in Europe. Pediatr Infect Dis J 24, 761\u2013765 (2005).","journal-title":"Pediatr Infect Dis J"},{"key":"30558_CR3","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","volume":"24","author":"AM Wendelboe","year":"2005","unstructured":"Wendelboe, A. M., Van Rie, A., Salmaso, S. & Englund, J. A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24, S58\u201361 (2005).","journal-title":"Pediatr Infect Dis J"},{"key":"30558_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","volume":"367","author":"NP Klein","year":"2012","unstructured":"Klein, N. P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B. & Baxter, R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 367, 1012\u20131019, https:\/\/doi.org\/10.1056\/NEJMoa1200850 (2012).","journal-title":"N Engl J Med"},{"key":"30558_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2012.6364","volume":"308","author":"SL Sheridan","year":"2012","unstructured":"Sheridan, S. L., Ware, R. S., Grimwood, K. & Lambert, S. B. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308, 454\u2013456, https:\/\/doi.org\/10.1001\/jama.2012.6364 (2012).","journal-title":"JAMA"},{"key":"30558_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","volume":"54","author":"SA Plotkin","year":"2012","unstructured":"Plotkin, S. A. & Gilbert, P. B. Nomenclature for immune correlates of protection after vaccination. Clin Infect Dis 54, 1615\u20131617, https:\/\/doi.org\/10.1093\/cid\/cis238 (2012).","journal-title":"Clin Infect Dis"},{"key":"30558_CR7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1086\/315318","volume":"181","author":"J Taranger","year":"2000","unstructured":"Taranger, J. et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 181, 1010\u20131013, https:\/\/doi.org\/10.1086\/315318 (2000).","journal-title":"J Infect Dis"},{"key":"30558_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","volume":"16","author":"JD Cherry","year":"1998","unstructured":"Cherry, J. D., Gornbein, J., Heininger, U. & Stehr, K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16, 1901\u20131906 (1998).","journal-title":"Vaccine"},{"key":"30558_CR9","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","volume":"16","author":"J Storsaeter","year":"1998","unstructured":"Storsaeter, J., Hallander, H. O., Gustafsson, L. & Olin, P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16, 1907\u20131916 (1998).","journal-title":"Vaccine"},{"key":"30558_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","volume":"3","author":"KH Mills","year":"2001","unstructured":"Mills, K. H. Immunity to Bordetella pertussis. Microbes Infect 3, 655\u2013677 (2001).","journal-title":"Microbes Infect"},{"key":"30558_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 17, 1055\u20131065, https:\/\/doi.org\/10.1128\/CVI.00131-10 (2010).","journal-title":"Clin Vaccine Immunol"},{"key":"30558_CR12","doi-asserted-by":"publisher","first-page":"AID-0019","DOI":"10.1128\/microbiolspec.AID-0019-2014","volume":"2","author":"DN Forthal","year":"2014","unstructured":"Forthal, D. N. Functions of Antibodies. Microbiol Spectr 2, AID-0019\u20132014, https:\/\/doi.org\/10.1128\/microbiolspec.AID-0019-2014 (2014).","journal-title":"Microbiol Spectr"},{"key":"30558_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep40328","volume":"7","author":"I van Twillert","year":"2017","unstructured":"van Twillert, I. et al. Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis. Sci Rep 7, 40328, https:\/\/doi.org\/10.1038\/srep40328 (2017).","journal-title":"Sci Rep"},{"key":"30558_CR14","doi-asserted-by":"publisher","first-page":"ftv081","DOI":"10.1093\/femspd\/ftv081","volume":"73","author":"JC Eby","year":"2015","unstructured":"Eby, J. C., Hoffman, C. L., Gonyar, L. A. & Hewlett, E. L. Review of the neutrophil response to Bordetella pertussis infection. Pathog Dis 73, ftv081, https:\/\/doi.org\/10.1093\/femspd\/ftv081 (2015).","journal-title":"Pathog Dis"},{"key":"30558_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1086\/520200","volume":"29","author":"S Romero-Steiner","year":"1999","unstructured":"Romero-Steiner, S. et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 29, 281\u2013288, https:\/\/doi.org\/10.1086\/520200 (1999).","journal-title":"Clin Infect Dis"},{"key":"30558_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1086\/381439","volume":"38","author":"U Heininger","year":"2004","unstructured":"Heininger, U., Cherry, J. D. & Stehr, K. Serologic response and antibody-titer decay in adults with pertussis. Clin Infect Dis 38, 591\u2013594, https:\/\/doi.org\/10.1086\/381439 (2004).","journal-title":"Clin Infect Dis"},{"key":"30558_CR17","doi-asserted-by":"publisher","unstructured":"Bart, M. J. et al. Complete Genome Sequences of Bordetella pertussis Isolates B1917 and B1920, Representing Two Predominant Global Lineages. Genome Announc 2, https:\/\/doi.org\/10.1128\/genomeA.01301-14 (2014).","DOI":"10.1128\/genomeA.01301-14"},{"key":"30558_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","volume":"27","author":"T Dorner","year":"2007","unstructured":"Dorner, T. & Radbruch, A. Antibodies and B cell memory in viral immunity. Immunity 27, 384\u2013392, https:\/\/doi.org\/10.1016\/j.immuni.2007.09.002 (2007).","journal-title":"Immunity"},{"key":"30558_CR19","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1016\/j.vaccine.2012.09.003","volume":"30","author":"AM Barkoff","year":"2012","unstructured":"Barkoff, A. M. et al. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine 30, 6897\u20136902, https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.003 (2012).","journal-title":"Vaccine"},{"key":"30558_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.vaccine.2011.10.048","volume":"30","author":"LH Hendrikx","year":"2011","unstructured":"Hendrikx, L. H. et al. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age. Vaccine 30, 51\u201358, https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.048 (2011).","journal-title":"Vaccine"},{"key":"30558_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1099\/jmm.0.020826-0","volume":"59","author":"T Dalby","year":"2010","unstructured":"Dalby, T., Petersen, J. W., Harboe, Z. B. & Krogfelt, K. A. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol 59, 1029\u20131036, https:\/\/doi.org\/10.1099\/jmm.0.020826-0 (2010).","journal-title":"J Med Microbiol"},{"key":"30558_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-108","volume":"12","author":"FH Osier","year":"2014","unstructured":"Osier, F. H. et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med 12, 108, https:\/\/doi.org\/10.1186\/1741-7015-12-108 (2014).","journal-title":"BMC Med"},{"key":"30558_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1128\/CVI.00081-07","volume":"14","author":"A Aase","year":"2007","unstructured":"Aase, A. et al. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway. Clin Vaccine Immunol 14, 855\u2013862, https:\/\/doi.org\/10.1128\/CVI.00081-07 (2007).","journal-title":"Clin Vaccine Immunol"},{"key":"30558_CR24","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1086\/374741","volume":"187","author":"PS Mobberley-Schuman","year":"2003","unstructured":"Mobberley-Schuman, P. S., Connelly, B. & Weiss, A. A. Phagocytosis of Bordetella pertussis incubated with convalescent serum. J Infect Dis 187, 1646\u20131653, https:\/\/doi.org\/10.1086\/374741 (2003).","journal-title":"J Infect Dis"},{"key":"30558_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1086\/377283","volume":"188","author":"SM Hellwig","year":"2003","unstructured":"Hellwig, S. M., Rodriguez, M. E., Berbers, G. A., van de Winkel, J. G. & Mooi, F. R. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 188, 738\u2013742, https:\/\/doi.org\/10.1086\/377283 (2003).","journal-title":"J Infect Dis"},{"key":"30558_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1084\/jem.20021153","volume":"197","author":"L Coutte","year":"2003","unstructured":"Coutte, L. et al. Role of adhesin release for mucosal colonization by a bacterial pathogen. J Exp Med 197, 735\u2013742, https:\/\/doi.org\/10.1084\/jem.20021153 (2003).","journal-title":"J Exp Med"},{"key":"30558_CR27","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.4049\/jimmunol.167.11.6545","volume":"167","author":"ME Rodriguez","year":"2001","unstructured":"Rodriguez, M. E. et al. Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 167, 6545\u20136551 (2001).","journal-title":"J Immunol"},{"key":"30558_CR28","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.1128\/IAI.68.12.6720-6728.2000","volume":"68","author":"ET Harvill","year":"2000","unstructured":"Harvill, E. T. et al. Multiple Roles for Bordetella Lipopolysaccharide Molecules during Respiratory Tract Infection. Infection and Immunity 68, 6720\u20136728 (2000).","journal-title":"Infection and Immunity"},{"key":"30558_CR29","doi-asserted-by":"publisher","first-page":"e20585","DOI":"10.1371\/journal.pone.0020585","volume":"6","author":"N Marr","year":"2011","unstructured":"Marr, N., Shah, N. R., Lee, R., Kim, E. J. & Fernandez, R. C. Bordetella pertussis Autotransporter Vag8 Binds Human C1 Esterase Inhibitor and Confers Serum Resistance. PLoS One 6, e20585 (2011).","journal-title":"PLoS One"},{"key":"30558_CR30","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1128\/IAI.69.5.3067-3072.2001","volume":"69","author":"MG Barnes","year":"2001","unstructured":"Barnes, M. G. & Weiss, A. A. BrkA Protein of Bordetella pertussis Inhibits the Classical Pathway of Complement after C1 Deposition. Infection and Immunity 69, 3067\u20133072 (2001).","journal-title":"Infection and Immunity"},{"key":"30558_CR31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/iai.62.2.722-725.1994","volume":"62","author":"RD Shahin","year":"1994","unstructured":"Shahin, R. D., Hamel, J., Leef, M. F. & Brodeur, B. R. Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun 62, 722\u2013725 (1994).","journal-title":"Infect Immun"},{"key":"30558_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0264-410X(01)00269-9","volume":"20","author":"DC Oliver","year":"2001","unstructured":"Oliver, D. C. & Fernandez, R. C. Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 20, 235\u2013241 (2001).","journal-title":"Vaccine"},{"key":"30558_CR33","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1111\/j.1742-4658.2011.08237.x","volume":"278","author":"C Locht","year":"2011","unstructured":"Locht, C., Coutte, L. & Mielcarek, N. The ins and outs of pertussis toxin. FEBS J 278, 4668\u20134682, https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08237.x (2011).","journal-title":"FEBS J"},{"key":"30558_CR34","doi-asserted-by":"publisher","first-page":"e0148507","DOI":"10.1371\/journal.pone.0148507","volume":"11","author":"I van Twillert","year":"2016","unstructured":"van Twillert, I. et al. The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections. PLoS One 11, e0148507, https:\/\/doi.org\/10.1371\/journal.pone.0148507 (2016).","journal-title":"PLoS One"},{"key":"30558_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/23744235.2015.1100323","volume":"48","author":"C Guevara","year":"2016","unstructured":"Guevara, C. et al. Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis. Infect Dis (Lond) 48, 177\u2013188, https:\/\/doi.org\/10.3109\/23744235.2015.1100323 (2016).","journal-title":"Infect Dis (Lond)"},{"key":"30558_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.micpath.2006.11.003","volume":"42","author":"TM Krunkosky","year":"2007","unstructured":"Krunkosky, T. M., Jordan, J. L., Chambers, E. & Krause, D. C. Mycoplasma pneumoniae host-pathogen studies in an air-liquid culture of differentiated human airway epithelial cells. Microb Pathog 42, 98\u2013103, https:\/\/doi.org\/10.1016\/j.micpath.2006.11.003 (2007).","journal-title":"Microb Pathog"},{"key":"30558_CR37","doi-asserted-by":"publisher","first-page":"e018594","DOI":"10.1136\/bmjopen-2017-018594","volume":"7","author":"H de Graaf","year":"2017","unstructured":"de Graaf, H. et al. Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. BMJ Open 7, e018594, https:\/\/doi.org\/10.1136\/bmjopen-2017-018594 (2017).","journal-title":"BMJ Open"},{"key":"30558_CR38","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.4049\/jimmunol.181.8.5587","volume":"181","author":"J Kamanova","year":"2008","unstructured":"Kamanova, J. et al. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J Immunol 181, 5587\u20135597 (2008).","journal-title":"J Immunol"},{"key":"30558_CR39","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1128\/IAI.68.12.7152-7155.2000","volume":"68","author":"CL Weingart","year":"2000","unstructured":"Weingart, C. L., Mobberley-Schuman, P. S., Hewlett, E. L., Gray, M. C. & Weiss, A. A. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 68, 7152\u20137155 (2000).","journal-title":"Infect Immun"},{"key":"30558_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/fmb.09.133","volume":"5","author":"NH Carbonetti","year":"2010","unstructured":"Carbonetti, N. H. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol 5, 455\u2013469, https:\/\/doi.org\/10.2217\/fmb.09.133 (2010).","journal-title":"Future Microbiol"},{"key":"30558_CR41","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1073\/pnas.73.6.1926","volume":"73","author":"EL Hewlett","year":"1976","unstructured":"Hewlett, E. L., Urban, M. A., Manclark, C. R. & Wolff, J. Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci USA 73, 1926\u20131930 (1976).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30558_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12865-015-0090-3","volume":"16","author":"D Valentini","year":"2015","unstructured":"Valentini, D., Ferrara, G., Advani, R., Hallander, H. O. & Maeurer, M. J. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis. BMC Immunol 16, 40, https:\/\/doi.org\/10.1186\/s12865-015-0090-3 (2015).","journal-title":"BMC Immunol"},{"key":"30558_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","volume":"5","author":"S Niewiesk","year":"2014","unstructured":"Niewiesk, S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 5, 446, https:\/\/doi.org\/10.3389\/fimmu.2014.00446 (2014).","journal-title":"Front Immunol"},{"key":"30558_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5, 520, https:\/\/doi.org\/10.3389\/fimmu.2014.00520 (2014).","journal-title":"Front Immunol"},{"key":"30558_CR45","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/iai.60.5.2101-2105.1992","volume":"60","author":"LL Steed","year":"1992","unstructured":"Steed, L. L., Akporiaye, E. T. & Friedman, R. L. Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes. Infect Immun 60, 2101\u20132105 (1992).","journal-title":"Infect Immun"},{"key":"30558_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0084-3","volume":"7","author":"C Brookes","year":"2018","unstructured":"Brookes, C. et al. Bordetella pertussis isolates vary in their interactions with human complement components. Emerg Microbes Infect 7, 81, https:\/\/doi.org\/10.1038\/s41426-018-0084-3 (2018).","journal-title":"Emerg Microbes Infect"},{"key":"30558_CR47","doi-asserted-by":"publisher","first-page":"e1006531","DOI":"10.1371\/journal.ppat.1006531","volume":"13","author":"ES Hovingh","year":"2017","unstructured":"Hovingh, E. S. et al. Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface. PLoS Pathog 13, e1006531, https:\/\/doi.org\/10.1371\/journal.ppat.1006531 (2017).","journal-title":"PLoS Pathog"},{"key":"30558_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0378-1097(03)00132-0","volume":"220","author":"MG Barnes","year":"2003","unstructured":"Barnes, M. G. & Weiss, A. A. Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol Lett 220, 271\u2013275 (2003).","journal-title":"FEMS Microbiol Lett"},{"key":"30558_CR49","doi-asserted-by":"publisher","first-page":"e85227","DOI":"10.1371\/journal.pone.0085227","volume":"9","author":"I van Twillert","year":"2014","unstructured":"van Twillert, I. et al. Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection. PLoS One 9, e85227, https:\/\/doi.org\/10.1371\/journal.pone.0085227 (2014).","journal-title":"PLoS One"},{"key":"30558_CR50","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3389\/fimmu.2017.01158","volume":"8","author":"V Marcellini","year":"2017","unstructured":"Marcellini, V. et al. Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B Cells. Front Immunol 8, 1158, https:\/\/doi.org\/10.3389\/fimmu.2017.01158 (2017).","journal-title":"Front Immunol"},{"key":"30558_CR51","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/mi.2012.54","volume":"5","author":"R Higgs","year":"2012","unstructured":"Higgs, R., Higgins, S. C., Ross, P. J. & Mills, K. H. G. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunology 5, 485\u2013500 (2012).","journal-title":"Mucosal Immunology"},{"key":"30558_CR52","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1182\/blood-2006-06-015461","volume":"109","author":"J Bestebroer","year":"2007","unstructured":"Bestebroer, J. et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109, 2936\u20132943, https:\/\/doi.org\/10.1182\/blood-2006-06-015461 (2007).","journal-title":"Blood"},{"key":"30558_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-1656(99)00155-8","volume":"75","author":"M Thalen","year":"1999","unstructured":"Thalen, M. et al. Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol 75, 147\u2013159 (1999).","journal-title":"J Biotechnol"},{"key":"30558_CR54","first-page":"83","volume":"5","author":"OaJ Westphal","year":"1965","unstructured":"Westphal, Oa. J. K. Bacterial Lipopolysaccharides Extraction with Phenol-Water and Further Applications of the Procedure. Methods in Carbohydrate Chemistry 5, 83\u201391 (1965).","journal-title":"Methods in Carbohydrate Chemistry"},{"key":"30558_CR55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","volume":"67","author":"NB Saunders","year":"1999","unstructured":"Saunders, N. B. et al. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun 67, 113\u2013119 (1999).","journal-title":"Infect Immun"},{"key":"30558_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1128\/CVI.00061-10","volume":"18","author":"RM Stenger","year":"2011","unstructured":"Stenger, R. M. et al. Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens. Clin Vaccine Immunol 18, 595\u2013603, https:\/\/doi.org\/10.1128\/CVI.00061-10 (2011).","journal-title":"Clin Vaccine Immunol"},{"key":"30558_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-1759(01)00329-5","volume":"252","author":"ME Rodriguez","year":"2001","unstructured":"Rodriguez, M. E., Van der Pol, W. L. & Van de Winkel, J. G. Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J Immunol Methods 252, 33\u201344 (2001).","journal-title":"J Immunol Methods"},{"key":"30558_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests. Machine Learning 45, 5\u201332, https:\/\/doi.org\/10.1023\/a:1010933404324 (2001).","journal-title":"Machine Learning"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30558-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:13:16Z","timestamp":1671610396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30558"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30558-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"7 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12039"}}